Inside Innovation

Affini-T Therapeutics, a cancer-focused biotech company with offices in Seattle, raised $175 million to pursue tech licenses to strengthen its cell therapy platform and drive

Frazier Life Sciences announced the closing of a $987 million funding for biopharmaceuticals, focusing on company creation and early-stage venture funding, along with 80% set

The University of Washington is expanding scientific programs into an 11-story building, including a wide range of tenants, where multiple fields can come together and

In the new Axios-Generation Lab Next Cities Index, Seattle is ranked as America’s most sought after post-graduation destination for college students. College students are drawn

Seagen, a biotech company based in Bothell, Washington, is partnering up with Sanofi to develop and commercialize antibody-drug conjugates (ADCs) for up to three cancer

Washington state’s Department of Commerce has awarded $500,000 grants to four organizations forming new innovation clusters in Washington as part of the “Innovation Cluster Accelerator”

Tasso, a Seattle-based biotech company, has been included in Fierce Medtech’s 2021 Fierce 15 list. This year’s class features innovators working to build new approaches

As current events unfold in Ukraine, Washington state’s prosperous life science ecosystem is coming together to show its support. Several Seattle-based companies including Seagen, Silverback

As new tech hubs sprout up around the country, Seattle remains a top metro area for attracting tech workers. While other cities gain ground amid

A-Alpha Bio, a Seattle-based biotech company, is collaborating with Lawrence Livermore National Laboratory, to support research into new therapies for COVID-19 variants. The research is

As more biotech startups are working with machine learning and computational methods to design new therapeutics and support testing, traditional tech venture capital firms such

Parse Biosciences announced $41.5 million in funding this week. The Seattle-based biotech startup, which focuses on single-cell RNA sequencing, sets itself apart from other companies